Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repligen Corp (NASDAQ:RGEN)

34.19
Delayed Data
As of 10:35am ET
 -0.52 / -1.50%
Today’s Change
21.11
Today|||52-Week Range
35.61
+10.93%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close34.71
Today’s open34.80
Day’s range34.19 - 34.91
Volume18,356
Average volume (3 months)234,664
Market cap$1.2B
Dividend yield--
Data as of 10:35am ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+21.43%
Earnings growth (this year)+25.57%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+25.14%
P/E ratio100.6
Price/Sales10.05
Price/Book6.96

Competitors

 Today’s
change
Today’s
% change
ACORAcorda Therapeutics ...+0.10+0.39%
LOXOLoxo Oncology Inc+0.01+0.02%
EBSEmergent BioSolution...+0.35+1.23%
AIMTAimmune Therapeutics...-0.20-0.86%
Data as of 10:51am ET, 03/24/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)$0.13
Annual revenue (last year)$104.5M
Annual profit (last year)$11.7M
Net profit margin11.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts


Search for Jobs